Automated quantification of cerebral microbleeds for ARIA-H monitoring in Aging and Alzheimer's Disease: A multicenter deep learning validation

We trained a self-configuring nnU-Net model for CMB segmentation in a heterogeneous multicenter sample (n=264), including 1.5T and 3T field strengths, SWI and T2*-GRE sequences, and community and clinical cohorts. Model performance was evaluated using 5-fold cross-validation with a focus on object-level detection metrics. Real-world performance was evaluated on scans from an unseen dataset of people with cerebrovascular disease (n=20). The model achieved 0.82 cluster Dice, 0.88 precision, and 0.77 sensitivity on hold-out test data. Notably, the model demonstrated a low false-positive rate, averaging 0.58 false positives (FPs) per scan, an improvement on existing publicly available models. The model achieved high performance in dataset of those with Alzheimer's disease and mild cognitive impairment (0.89 cluster Dice, 0.94 sensitivity), supporting its utility in clinical settings where ARIA-H monitoring is critical. In external validation, the model maintained high robustness with 0.79 sensitivity and 0.95 FPs per scan. By leveraging a heterogenous training strategy and a self-adapting architecture, we demonstrate that deep learning can achieve high-precision CMB detection that is robust to domain shifts. The low FP rate suggests this publicly available pipeline is suitable for automated screening and lesion counting in heterogenous large-scale clinical trials, reducing the burden of manual quantification.